Welcome to Ananda Developments

Ananda Developments’ vision is to become a leading UK grower and provider of carbon neutral, high quality consistent medical cannabis for the domestic and international markets.

We believe that the legalisation of, and increased access to, medical cannabis in the UK and globally will continue. Over the last few years, as the UK health authorities and government agencies have gathered more evidence to support the use of medical cannabis to treat a range of illnesses and conditions and we continue to see medical cannabis being more widely available.

Ananda Developments is listed on the AQSE Growth Market in London and provides a UK based listed platform for cannabis investors to gain exposure to the sector.  Click here for a list of brokers trading in AQSE securities.


Our Investments

Ananda Developments holds 100% of Tiamat Agriculture Limited, which owns 50% of DJT Group Limited which has been granted a Home Office licence to grow >0.2% THC cannabis in the United Kingdom.

Ananda holds 180 shares (0.9%) in ICAN, an Israel based medical cannabis incubator and conference company.


Become knowledgeable about medical cannabis

Simply add your name and email below to receive Investor Updates which highlight our progress to growing medical cannabis in the UK. You can also receive our Medical Cannabis Research Roundups which provide easy-to-read summaries of recent scientific research.

Subscribe!

* indicates required



 

Interests
Investor

 

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at ir@anandadevelopments.com. We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.